Rapid Therapeutic Science Laboratories, Inc is focused on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The Company is also focusing on manufacturing its own branded metered dose inhaler (MDI) under the inhaler brand name.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	85.73K 74.3K 69.55K 63.46K 119K 8.18M 121K 816K 320K 4.09M 322K 315K 13.65M	P/E 2021	-16.6x	P/E 2022	-3.24x
Enterprise Value	3.92M 3.39M 3.18M 2.9M 5.46M 374M 5.55M 37.26M 14.6M 187M 14.7M 14.38M 624M	EV / Sales 2021	93,978,853,933x	EV / Sales 2022	-
Free-Float	100%	Yield 2021 *	-	Yield 2022	-

14/08/23	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
12/05/23	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
30/03/23	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/03/23	Rapid Therapeutic Science Laboratories, Inc. Auditor Raises 'Going Concern' Doubt	CI
10/11/22	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
12/08/22	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
30/05/22	Rapid Therapeutic Science Laboratories, Inc. announced that it has received $0.35 million in funding	CI
11/05/22	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
16/03/22	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
15/03/22	Rapid Therapeutic Science Laboratories, Inc. Auditor Raises 'Going Concern' Doubt	CI
27/01/22	Rapid Therapeutic Science Laboratories, Inc. announced that it has received $0.4 million in funding	CI
17/01/22	Rapid Therapeutic Science Laboratories, Inc. announced that it has received $0.15375 million in funding from Sixth Street Lending, LLC	CI
11/11/21	Rapid Therapeutics Science Laboratories Announces Launch of its New Facility Located in Addison, Tex	CI

06/12/23	Rapid Therapeutic Science Laboratories : Change in Certifying Accountants - Form 8-K	PU
30/03/23	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
21/03/23	White House Office of Management and Budget review on Cannabis-Derived Products confirms Rapid Therapeutic Science Laboratories’ Long-Term Strategy	AQ
13/12/22	Rapid Therapeutic Science Laboratories Updates Patents	AQ
10/11/22	RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ

Manager	Title	Age	Since
Donal Schmidt CEO	Chief Executive Officer	65	14/11/2019
D. Watler DFI	Director of Finance/CFO	77	14/11/2019

Director	Title	Age	Since
D. Watler BRD	Director/Board Member	77	14/11/2019
Donal Schmidt BRD	Director/Board Member	65	14/11/2019

Rapid Therapeutic Science Laboratories, Inc. Share Price Other OTC

Stocks

RTSL

US7534311052

Pharmaceuticals

Valuation: Rapid Therapeutic Science Laboratories, Inc.

Latest news : Rapid Therapeutic Science Laboratories, Inc.

Press Releases: Rapid Therapeutic Science Laboratories, Inc.

Managers and Directors: Rapid Therapeutic Science Laboratories, Inc.

Alternative Medicine

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.	-.--%	-7.81%	-	-	1.9K
YUNNAN BAIYAO GROUP CO.,LTD	-0.70%	-1.68%	-9.25%	-6.56%	13.44B
DONG-E-E-JIAO CO., LTD.	-0.81%	-1.79%	+4.58%	+3.87%	5.07B
BEIJING TONGRENTANG CO., LTD	-0.99%	-3.41%	-32.01%	-56.10%	5.06B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-0.12%	+0.48%	+4.20%	-30.78%	4.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.13%	-2.70%	-13.13%	-5.79%	3.66B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-0.93%	-2.77%	-3.64%	+2.27%	3.5B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.64%	-2.02%	-4.55%	+16.50%	3.44B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.44%	0.00%	-13.66%	-16.09%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+0.71%	-1.18%	-2.89%	+42.72%	1.88B
Average	-0.50%	-0.33%	-7.82%	-5.55%	4.74B
Weighted average by Cap.	-0.66%	-0.34%	-8.46%	-9.29%

	2021	2022
Net sales	0 0 0 0 0 0.05 0 0.01 0 0.03 0 0 0.09	-
Net income	-2.87M -2.49M -2.33M -2.12M -3.99M -274M -4.06M -27.28M -10.69M -137M -10.77M -10.53M -457M	-1.79M -1.56M -1.46M -1.33M -2.5M -171M -2.54M -17.07M -6.69M -85.68M -6.74M -6.59M -286M
Net Debt	1.79M 1.55M 1.45M 1.33M 2.5M 171M 2.54M 17.06M 6.68M 85.6M 6.73M 6.59M 286M	3.83M 3.32M 3.11M 2.84M 5.34M 365M 5.43M 36.44M 14.28M 183M 14.38M 14.07M 610M